Efficacy evaluation of bioactive regenerative polypeptide complex channeled by microneedle for periorbital skin rejuvenation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900021425

Enrollment

Unknown

Registered

2019-02-21

Start date

2019-03-01

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periorbital skin aging

Interventions

1:bioactive regenerative polypeptide complex channeled by microneedle

2:radiofrequency therapy combined with bioactive regenerative polypeptide complex channeled by microneedle

Eligibility

Sex/Gender

Female

Age

35 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged 35 to 55 years; 2. Volunteers with periorbital skin aging, sagging, fine wrinkle; 3. Volunteers with intact periorbital skin.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding; 2. Allergic to the experimental drug or the ingredient; 3. Accompanied with severe systematic diseased or mental problem; 4. used filling treatment, or hyaluronic acid or laser treatment within the last three months; 5. Treated by systemtic oral steroid, collagen, hyaluronic acid within the last three months; 6. participating in other trials; 7. Researchers consider that Volunteers are not suitable to participate in this study.

Design outcomes

Primary

Measure	Time frame
skin biophysical parameters;	—

Countries

China

Contacts

Public ContactFenglin Zhuo

Department of Dermatology, Beijing Friendship Hospital, Capital Medical University

zflsunny@hotmail.com+86 15910895068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026